Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-16

Clinical Trial Update: Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant [NA]

View source ↗

Summary

A completed clinical trial evaluated the use of norethindrone acetate to manage bleeding associated with the etonogestrel contraceptive implant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etonogestrel (etonogestrel)
  • Norethindrone acetate (Norethindrone acetate)

Snippet

Sponsor: Norton Healthcare | Conditions: Etonogestrel Contraceptive Implant, Bothersome Bleeding | NA | Status: COMPLETED | Results posted: 2022-03-16